Regulation & policy

Inside the European Court of Justice

Lisbon Treaty could permit EU health claim challenges

By Shane Starling

A Lisbon Treaty-led broadening of the rights of individuals and corporations to act against European Union law could permit generic, article 13 health claim challenges, even though they, “are not addressed to individuals”, according to an EU food law...

Banned drug sibutramine rears its ugly head again

Banned drug sibutramine found in weight loss pills

By Shane Starling

The banned pharma ingredient sibutramine has been found at dangerously high levels in a Taditional Chinese Medicine weight loss supplement, the UK Medicines and Healthcare products Regulatory Agency (MHRA) said Friday.

HiPPy times for one German company (and potentially others) as EFSA's health claims panel approves an article 14 thiamin claim for neural development in under-3s

EFSA health claim opinion

EFSA approves vitamin B1-infant brain health claim

By Shane Starling

The European Food Safety Authority (EFSA) has approved a health claim linking thiamin (vitamin B1) and “normal neurological development and function” in infants and children up to three years of age.

Body shaping and toning is the predominate CLA claim, although to date, EFSA's health claims panel has not accepted CLA claim-backing science

CLA gains EU hearing as Novel Foods status beckons

By Shane Starling

Nine months after the European Food Safety Authority (EFSA) handed in a positive safety assessment for conjugated linoleic acid (CLA), the weight management ingredient will be assessed by the European Commission as it continues its protracted journey...

Weight loss is never easy especailly when palpitations, gastritis, abdominal pain and insomnia are part of the package

UK warns against herbal weight loss supplement

By Shane Starling

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning against a Traditional Chinese Medicine (TCM) after adverse reactions indicated it contained an unauthorised, unspecified pharma ingredient.

Glucosamine joint health ads went “too far”, says ASA

By Shane Starling

The UK Advertising Standards Authority (ASA) has ruled against glucosamine-joint health claims being made by supplements manufacturer Seven Seas, despite the claims being almost identical to its own approved version.

Some MEPs are calling for a revision of DHA-infant ye development claims

MEPs question omega-3 baby milk benefits

By Shane Starling

Members of the European Parliament (MEPs) are questioning whether omega-3 form DHA can benefit infant eye sight, despite the nutrient winning endorsement from one of the world’s toughest claims assessment agencies – the European Food Safety Authority...

Bread: To fortify or not to fortify? That is the folic acid question concerning some New Zealand parliamentarians

Calls for voluntary folic acid fortification in NZ grow

By Shane Starling

New Zealand opposition party members are calling on the government to fortify the country’s flour supply and bread output with folic acid, following reports of the success of a similar program across the Tasman Sea in Australia.

Brain claims are OK, says ASA

Vitamin-herb brain claims are ok, finds UK authority

By Shane Starling

The UK branch of German pharma player Boehringer Ingelheim has had brain health adverts for a vitamin-based medicine backed by local watchdog, the Advertising Standards Authority (ASA).

European nutrition science will go on, but will it earn health claims?

Special edition: Outsourcing

CROs (slowly) piece together EFSA's health claim science puzzle

By Shane Starling

In the second part of this special series on global outsourcing trends NutraIngredients explores how the European Union nutrition and health claims regulation (NHCR) is impacting activity in the contract research organisation (CRO) sector.

Ginkgo biloba

UK ASA rules against botanical marketing

By Shane Starling

UK firm Healthspan has been told to amend marketing materials for herbal-based blends after the Advertising Standards Authority (ASA) found advertorial materials in breach of its fair marketing code for making medicinal and unauthorised claims.

UK watchdog raps Coke Vitaminwater ads

UK watchdog raps Coke Vitaminwater ads

By Shane Starling

UK advertising watchdog, the Advertising Standards Authority (ASA), has ruled against Coca-Cola Vitaminwater adverts for the second time in 18 months.

The ASA may be visiting a website near you soon...

UK advertising watchdog promotes new online powers

By Shane Starling

The UK Advertising Standards Authority (ASA) has launched a six-week campaign to educate industry and consumers about its new remit to police online communications such as corporate website messaging and social networking sites.

The eyes have it, but the brain

EC hands omega-3 mixed results

By Shane Starling

An article 14 children’s development health claim submitted to the European Union by drug giant Merck linking omega-3 form DHA with infant visual development has been approved at committee level by the European Commission.

Industry is finding the EU health claims system hard to swallow

Are health claims making your business sick?

By Shane Starling

2010 has been another tough year for the European functional food and supplements industries as health claim rejections have continued to flood in, leaving some in a state of high anxiety, fear and dread. Others are just mildly annoyed at a situation...

EFSA affirms soy protein health claim rejection

EFSA explains soy protein claim rejection

By Shane Starling

The European Food Safety Authority health claims panel has defended its controversial rejection of a soy protein-cholesterol lowering submission in July this year by highlighting the fact the industry agreed to its tight definition of soy protein.

EFSA gives thumbs down to pre-submision meetings

EFSA Board: No resources for pre-submission claim meetings

By Shane Starling

The European Food Safety Authority (EFSA) confirmed at its Board Management meeting last week that the resources do not exist to accommodate meetings between its health claims panel and parties before claim submissions are formally made.

Could pre-health claim submission meetings actually save resources?

Probiotics industry unites over EFSA claims treatment

By Shane Starling

Four groups with an interest in pre- and probiotics will today send a letter to the European Commission and European Food Safety Authority spelling out their ongoing concerns with the European Union health claims system that, to date, has unanimously...

Bischoff: Who will answer the

EFSA gut/immune health meeting

Health claims: Is the idea of disease risk factors, itself diseased?

By Shane Starling

Differentiating between disease risk factors and disease reduction in the way that the 2006 nutrition and health claim regulation does is too arbitrary and needs revision, according to a German nutrition professor. But if such a change is needed, who...

Vitamin D can help the elderly reduce falls, says DSM, in a new submission

DSM submits vitamin D health claim for “falling”

By Shane Starling

DSM Nutritional Products has submitted an article 14 disease risk reduction health claim linking consumption of a proprietary blend of vitamin D2 and D3 and reduced risk of falling over among the elderly.

How to build an article 13.5 dossier

How to build an article 13.5 dossier

By Shane Starling

The rejection of so many health claim submissions by the European Food Safety Authority is creating a major headache for the EU functional foods and food supplements industries, with many looking at resubmissions under article 13.5 of the regulation.

How significant will the botanicals reprieve turn out to be?

NHCR botanicals removal provides a longevity loophole?

By Shane Starling

The European Commission decision to remove around 2000 submissions for botanical extracts from the 2006 nutrition and health claims process will allow substances to remain on-market, and may provide a loophole to help companies thinking about herbal medicinal...

Yakult wants a word with the NDA about its rejected probiotic immunity claim

Yakult: EFSA must recognise cold symptoms

By Shane Starling

Japanese probiotics giant Yakult says its recent EFSA probiotic health claim rejection discounted peer-review validated respiratory tract health measures, and called on the European Commission to facilitate a discussion on the matter.

NDA panelist: Restoring the immune sytem could yield claims

EFSA gut/immune health meeting

NDA panelist offers restored immune system claims hope

By Shane Starling

Restoring a suppressed immune system to full-function could win a health claim, EFSA health claim panelist, Henk van Loveren said at last week’s gut/immune health meeting in Amsterdam.

How health claims could impact marketing ethics

How health claims could impact marketing ethics

The tough health claims environment in Europe could turn manufacturers towards more subtle – and maybe less ethical – marketing approaches, believes Henry Dixon of PR firm BDB.

Follow us

Products

View more

Webinars